Table 5. Top altered pathways from blood following kidney transplant.
Week 1 | Month 3 | Month 6 |
---|---|---|
Higher Levels Than at Baseline | ||
Axonal Guidance Signaling (12) | IL-8 Signaling (6) | Antiproliferative Role of Somatostatin Receptor 2 (2) |
LXR/RXR Activation (6) | Complement System (3) | Spermine and Spermidine Degradation I (1) |
Airway Pathology in Chronic Obstructive Pulmonary Disease (2) | Airway Pathology in Chronic Obstructive Pulmonary Disease (2) | Melatonin Degradation II (1) |
Lower Levels Than at Baseline | ||
T Cell Receptor Signaling (18) | T Cell Receptor Signaling (16) | Granulocyte Adhesion and Diapedesis (8) |
iCOS-iCOSL Signaling in T Helper Cells (17) | iCOS-iCOSL Signaling in T Helper Cells (16) | Agranulocyte Adhesion and Diapedesis (8) |
CTLA4 Signaling in Cytotoxic T Lymphocytes (13) | CTLA4 Signaling in Cytotoxic T Lymphocytes (12) | Communication between Innate and Adaptive Immune Cells (6) |
Higher and Lower Levels, Combined | ||
T Cell Receptor Signaling (18) | T Cell Receptor Signaling (16) | Granulocyte Adhesion and Diapedesis (17) |
iCOS-iCOSL Signaling in T Helper Cells (17) | iCOS-iCOSL Signaling in T Helper Cells (16) | Agranulocyte Adhesion and Diapedesis (14) |
CTLA4 Signaling in Cytotoxic T Lymphocytes (14) | CTLA4 Signaling in Cytotoxic T Lymphocytes (12) | Macropinocytosis Signaling (8) |
Top canonical gene pathways altered at week 1, months 3 and 6 compared to baseline using Ingenuity Pathway Analysis of DEGs with false discovery rate (FDR) < 0.01 and 2 or greater fold change. The number of DEGs in the pathway is shown in parentheses.
DEG = Differentially Expressed Gene.
Baseline = prior to transplant.